CIC 2011

About Us

Keynote Speakers

Charles Barber Charles Barber is a lecturer in psychiatry at Yale University School of Medicine and author of two prominent books on mental health, Songs from the Black Chair: A Memoir of Mental Interiors, and Comfortably Numb: How Psychiatry Medicated a Nation. His writing has appeared in the New York Times, the Washington Post, Scientific American Mind, The Nation and many other publications, and has spoken about mental health issues on NPR’s Fresh Air, CNN, C-Span, and The Early Show. He worked in shelters for the homeless mentally ill for ten years in New York City. Barber is currently writing a novel about a depressed detective.

Plenary Session – October 6th, 9:00 AM

Comfortably Numb: How Psychiatry Medicated a Nation

The plenary session will provide an overview of our medicated nation, particularly as it pertains to psychiatric medications -- the most widely used class of medications by Americans. I will profile the current state of the landscape and provide an historical overview of 'The Perfect Storm' of the factors (YV advertising, managed care, expansion of diagnosis, etc) that led to our current situation.

Breakout Session – October 7th, 9:45 AM

The Human Factor: Alternative Approaches to Mental Health, With and Without Psychotropic Medications

The breakout session will cover alternative approaches and treatments to mental health, including motivational interviewing, cognitive behavioral therapy and other therapies, and the use of peer supports. I will describe these approaches and how they can be utilized as both a complement to psychiatric medications, and on their own. Attendees will gain a better understanding of a broader, more holistic approach to psychiatric treatment.
Dr. Michael Carome Michael A. Carome, M.D., currently is Deputy Director of Public Citizen’s Health Research Group. Prior to joining Public Citizen in 2011, he was Associate Director for Regulatory Affairs, Office for Human Research Protections (OHRP), Department of Health and Human Services from 2002-2010; Staff Nephrologist at the Walter Reed Army Medical Center’s (WRAMC’s) Department of Medicine from 1992-2010; and a Commissioned Corps officer in the U.S. Public Health Service (PHS), attaining the rank of Captain prior to his retirement from the PHS. Earlier in his federal career, he served as Director, Division of Compliance Oversight, OHRP; Chief of the Compliance Oversight Branch in the Office for Protection from Research Risks, National Institutes of Health (NIH); and Assistant Professor of Medicine, Department of Medicine, Uniformed Services University of Health Sciences. He earned his undergraduate Bachelor of Science degree in psychology at Georgetown University and his medical degree at Case Western Reserve University. He completed his internal medicine residency and nephrology fellowship training at WRAMC. During his fellowship training, he was a Guest Researcher at the Renal Cell Biology Section, National Institute of Diabetes and Digestive and Kidney Diseases, NIH. Dr. Carome is a Fellow in the American College of Physicians.

The main home page for Public Citizen:

Plenary Speech – October 6 at 11:45 AM

Pain, Obesity, and Alzheimer’s Disease: Public Citizen’s Efforts to Have FDA Ban Three Drugs [presentation]


After a brief general overview of Public Citizen’s Health Research Group’s activities regarding drug safety, Dr. Carome will discuss Public’s Citizen’s efforts to have three drugs removed from the market in the United States. The three drugs to be discussed are Darvon (generic name propoxyphene), Meridia (generic name sibutramine), and Aricept 23 (generic name donepezil). The discussion will highlight failures by the Food and Drug Administration to take appropriate and timely action to protect the American public from these unsafe drugs.

Breakout Session – October 6 at 1:30 PM

Pharmaceutical Industry Influence on Medical Practice and the Use of Drugs [presentation]

This session will explore various measures taken by pharmaceutical companies to influence the prescribing practices of physicians and promote the use of their medications. This will include a discussion of advertising practices, the engagement of thought leaders and expert physician consultants, influence over the development of clinical practice guidelines, and illegal off-label promotion of drugs. This session will explore various measures taken by pharmaceutical companies to influence the prescribing practices of physicians and promote the use of their medications. This will include a discussion of advertising practices, the engagement of thought leaders and expert physician consultants, influence over the development of clinical practice guidelines, and illegal off-label promotion of drugs.


Additional Conference Speakers

Devin J Koontz

Devin Koontz, Public Affairs Specialist for the Food and Drug Administration, is the Denver District's spokesperson to media, congressional staff, federal, state and local regulatory agencies, health professionals, consumers, academia, and regulated industry associations in CO, NM, UT, and WY. He provides information on all areas of FDA's broad regulatory authority. He leads the agency’s field communication program as chair of the ORA Public Affairs Executive Council and also occasionally mediates employment disputes for other federal agencies based in the Denver area. Devin is a Colorado native and has been with the agency since 1991. He is a proud graduate of the Metropolitan State College of Denver where he earned a BA in Technical Communications.

Breakout session, Thursday Oct. 6 at 10:30

“Implications of a Globalized Drug Supply and Strategies for the 21st Century”

Global production of all FDA-regulated goods, including pharmaceutical products, has exploded over the past ten years. In fact, FDA regulated imports have quadrupled since 2000. In addition to an increase in imported finished products, manufacturers increasingly use imported materials and ingredients in their U.S. production facilities, making the distinction between domestic and imported products obsolete. There are more products, more manufacturers, more countries with emerging industries and more consumer and patient access that ever before. A dramatic change in strategy must be implemented. The FDA and its global regulatory partners recognize this new reality and realize it will take a proactive and collaborative approach to address the challenges we face. The FDA must further collaborate and leverage in order to close the gap between import levels and regulatory resources. In order to cope with the fundamental global shifts on the horizon, the FDA will have to substantially and fundamentally revise our approach to global product safety. Historical tools, activities and approaches are no longer sufficient. The presenter will discuss the impact of international trade on the United States pharmaceutical supply, such as safety concerns and counterfeit products. Participants will not only understand the nature and scope of the challenges posed by this increasingly globalized industry, but will also gain an awareness of the efforts and strategies that are being implemented to address these issues and protect the public health.

Picture not available

Perry McCoy has been in federal law enforcement for 21 years. He has spent the last 16 years working for the Bureau of Land Management at numerous duty stations. McCoy loves being outdoors and outdoor activities.

Oct. 7th, 9:45 to 10:45


Drugs and YOUR Public Lands


This will be a powerpoint presentation of different drug activities that are occurring on Public Lands, the hazardous materials left behind as of result of the activity and what the BLM does to attempt to combat illegal drug activities on lands owned by the taxpayers.

Donna Artery

Dr. Donna Artery is a Pharmacist Consultant for the State of Wyoming, Department of Health.  She received a doctorate in pharmacy from the University in 2006.  Previously, she worked for School District # 1 in Wheatland Wyoming for 20 years. 

Panel Discussion, Thursday, October 6, 1:30 PM.


Prescription Drug Abuse and Misuse:  Implications for Doctors, Patients and Law Enforcement


Our panel will discuss the scope of the prescription abuse problem in Wyoming.  We will also provide some information on what we are doing to help educate healthcare providers and the public about the problem and tools they can use to prevent it.

Elizabeth (Betsy) Goudey Elizabeth (Betsy) Goudey graduated from the UW College of Law in 1982 and practiced law locally from 1982 until 1986. She was offered the position of UW Students’ Attorney in 1986 and recently celebrated her 25 year anniversary in that position. Having dealt with thousands and thousands of student clients in all issues of the law, civil, criminal and administrative, she has developed an in depth understanding of legal issues that are common to all university and college communities.
Breakout Session – October 6th at 10:30

Alcohol, Wyoming Law and You

This presentation is aimed at students attending the conference and is a discussion of law enforcement/ citizen interactions and how the different levels of interactions can trigger different levels of the exercise of a person’s 4th Amendment right to be free from unreasonable searches and seizures. The different scenarios presented do involve issues commonly arising from the consumption of alcohol (a subject with which most students are familiar). This workshop has been presented many times on campus to students and almost always has been extremely well received by the attendees. The presentation has often turned into a very interactive question and answer session.
Kebin Haller Kebin Haller is the Deputy Director, Wyoming Division of Criminal Investigation, with over 20 years of law enforcement experience. He earned a BA in the Administration of Justice from the University of Wyoming.

Panel Discussion -

Prescription Abuse and Misuse in Wyoming (see similar)
Jennifer Hovarth Jennifer Horvath started in 2007 as the first staff attorney at the Wyoming Chapter of the ACLU. Previously, she worked for seven years at the Defender Association of Philadelphia, in both the trial and appellate divisions. She is a graduate of University of North Carolina School of Law.

Thursday, Oct. 6, Panel Discussion, 7:00 PM

Medical Marijuana: Policy Issues

This panel will discuss various public policy aspects of medical marijuana. Larimer County Commissioner Steve Johnson will provide the perspective of a local government official dealing with the issue in a state (Colorado) where medical marijuana is legal but regulated. Wyoming ACLU attorney Jennifer Horvath will present the issue from the perspective of individual civil rights. Law professor Stewart Young will present the federal/state law enforcement clash, from the perspective of a former federal prosecutor in California. Some questions to be addressed for Wyoming, a state where medical marijuana is not legal, might be: Is there a need for medical marijuana to treat certain medical conditions? Do consumers have a right to access this treatment? What social issues or consequences are associated with medical marijuana in other states where it is legal? What is the nature of the federal/state law enforcement conflict that is involved in states where medical marijuana has been legalized?
Steve Johnson Steve Johnson is a Larimer County Commissioner in Fort Collins Colorado. He took office in January of 2009. Johnson is a veterinarian who has practiced veterinary medicine in Loveland for 16 years. He has taught high school in Fort Collins and currently teaches organic chemistry at Colorado State University (CSU). He has a B.S. in chemistry from CSU, and a Doctorate of Veterinary Medicine from CSU.

Thursday, Oct. 6, Panel Discussion, 7:00 PM

Medical Marijuana: Policy Issues (see above)
Carol Kobulnicky

Dr. Carol J. H. Kobulnicky earned her MS and PhD from the University of Wisconsin-Madison in Social and Administrative Pharmacy, after having worked as a pharmacist in Milwaukee, WI.  She is an Associate Professor at the University of Wyoming School of Pharmacy where she instructs pharmacy students in the areas of professional communication, health behavior theory, cultural competency and practice management.  Her primary research emphasis is motivated by her desire to foster and improve patient self-advocacy.  Dr. Kobulnicky conducts research to better understand and improve cancer patients' experiences with information overload, and to empower patients in the areas of self-management and self-monitoring.  She also enjoys working to increase and improve inter-professional education opportunities in the UW College of Health Sciences, innovating in the classroom and studying the impact of pedagogical changes to improve student learning, and helping pharmacy students gain an interest in research and teaching.  Her passion for education and self-advocacy extends beyond the university and health care settings and into the community where she serves as an active board member of Laramie Montessori Community Organization.

Breakout Session, Thursday, Oct. 6th, 2:45 – 3:45

Complementary and Alternative Medicine Use in the U.S.: Facts, Figures and Controversies [presentation]

The presentation will include an overview of what Complementary and Alternative Medicine (CAM) is, how prevalent it is in the U.S., who is more likely to use CAM, and predominant reasons for use.  Controversies will be explored including economic, legal and practice-based philosophies.
Trudy Liberman

Trudy Lieberman, a journalist for 43 years, is a contributing editor to the Columbia Journalism Review where she blogs about health care and retirement at  She is also a fellow at the Center for Advancing Health where she blogs about health at  She was recently director of the health and medical reporting program at the Graduate School of Journalism, City University of New York and had a long career at Consumer Reports specializing in insurance, health care and health care financing.  She was also the director of the Center for Consumer Health Choices at Consumers Union.  She is a contributor to The Nation, and has written a column about health and the marketplace for the Los Angeles Times.  Lieberman began her career as a consumer writer for the Detroit Free Press where her reporting became a model for consumer writers across the country.

She has won 26 national and regional reporting awards and other honors, including two National Magazine Awards, 10 National Press Club Awards, five Society of Professional Journalists Deadline Club Awards, two Fulbright Fellowships---a senior scholar award to study health care in Japan and a senior specialist award to participate in training conferences for European health journalists, a John J. McCloy Fellowship to study health care in Germany, a Joan Shorenstein Fellowship from Harvard University to study media coverage of medical technology, and an honorary doctorate of humane letters from the University of Nebraska. She is the author of five books including Slanting the Story the Forces That Shape the News and the Consumer Reports Guide to Health Services for Seniors, which was named one of the best consumer health books for 2000 by Library Journal.  She is completing another book about health reform in America to be published in 2012 by the University of California Press.

Lieberman is an adjunct associate professor of public health at City University of New York.  She has taught media ethics in the Science, Health and Environmental Reporting Program at New York University, has been an adjunct professor of journalism at Columbia University, and was a Beamer-Schneider SAGES Fellow at Case Western Reserve University in 2006 where she has taught courses on media ethics and the ethics of health care delivery.  In 2007, she was appointed the James H. Ottaway visiting journalism professor at SUNY New Paltz where she taught a course on the media and the marketplace.  She is the immediate past president of the Association of Health Care Journalists, a professional organization of over 1000 journalists who cover health and medicine and serves on the board of directors for the organization.  She is currently a national advisory council member of the California Health Benefits Review Program.  She has served on the board of directors for the National Committee for Quality Assurance, the Medicare Rights Center, and Village Care of New York.  Lieberman appears on many panels and lectures widely on health care in the U.S.  She holds a B.S. with distinction from the University of Nebraska and earned a certificate in business and economics journalism from Columbia University’s Graduate School of Journalism where she was a Knight-Bagehot Fellow in 1976-77.

Plenary Session, Friday, October 7th, 8:30 – 9:30 AM

Marketing Drugs to Consumers:  Should You Take That Drug?

What consumers don't know about drug companies can hurt them.  With billions of dollars in profits at stake, pharmaceutical giants spend lavishly to get their products into the hands of consumers.  Are these what the patients really need?    This talk will explore how big Pharma gets its way.
Linda Martin Linda Martin is an Associate Professor of Social and Administrative Pharmacy at the University of Wyoming, earned her BS in Pharmacy and MBA from the University of Wyoming and her Doctor of Pharmacy from Creighton University. Dr. Martin is Board Certified in Pharmacotherapy. She was the Coordinator of the University of Wyoming Drug Information Center before changing to her current faculty position in 2000. Dr. Martin teaches Drug Literature Evaluation, Pharmacoeconomics, and Drug Use Process (the social and behavioral aspects of using medications). Her research interests include health outcomes related to medication use and pharmacoeconomics in special populations (older adults, women, lower socioeconomic levels); medication and digital literacy, especially in the older adult; and student personalities and success. Her association memberships and service are extensive.

Breakout Session – October 6th, 10:30 AM

Conundrums and Controversies: Medication use in humans and the limitations of evidence-based practice

Every day the media reports some major study or finding about medication. This may be a new breakthrough, a potentially serious adverse effect, or information that refutes earlier information. This program will cover recent stories and what that means to you as the consumer of these medications.
Mike Massie Mike Massie - After receiving a master’s degree in history from UW, Mike worked in public history for twenty years, in addition to being as an adjunct instructor in history at the University. For the past twelve years, he has been employed in the developmental disabilities field and is presently the executive director of Child Development Services of Wyoming, a private membership organization of the state’s developmental preschools. He served in the state legislature for 16 years.
Dave McCaffrey

Dr. David J. McCaffrey is a Professor of Pharmacy Administration and a Research Professor in the Center for Pharmaceutical Marketing and Management at The University of Mississippi School of Pharmacy.  He received his pharmacy degree from the University of Maryland and his graduate degrees from the University of Mississippi.  Dr. McCaffrey's research areas of interest lie within the fields of suboptimal medication consumption (specifically initial noncompliance), pharmacists’ influence on the product selection decision, the influence of direct-to-consumer advertising of medications on post-exposure information search, and patient satisfaction with health care services.  His research funding comes from pharmacy organizations and other health care organizations, pharmaceutical companies, and state and federal agencies.

Breakout Session, Thursday, October 6, 1:30 PM.


Throwing the baby out with the bathwater?  An examination of direct-to-consumer advertising of prescription medications


This presentation will focus on the benefits and challenges associated with the promotion of prescription medications directly to consumers.  Rather than focus on one perspective, this presentation will examine patient attitudes, provider attitudes, the position of Pharma companies, as well as the policies of the Food and Drug Administration (FDA).
Dee Pridgen Dee Pridgen is the Carl M. Williams Professor of Law and Social Responsibility, at the University of Wyoming’s College of Law, where she has taught since 1982. Her subjects include Consumer Protection, Contracts, Antitrust, and Payment Systems. She received her Juris Doctorate in 1974, from New York University, and a B.A. in 1971, from Cornell University. She is a member of the Order of the Coif and Phi Beta Kappa. Pridgen has been a Fulbright Scholar/Lecturer at Tokyo University in Japan and a Visiting Professor of Law at the University of Baltimore School of Law, the University of Maryland School of Law, and the Catholic University of America, Columbus School of Law. She also served as a Staff Attorney, for the Federal Trade Commission, Bureau of Consumer Protection, Washington, D.C. from 1978-82. Pridgen's publications include two treatises aimed at practicing attorneys, CONSUMER PROTECTION AND THE LAW, and CONSUMER CREDIT AND THE LAW, coauthored with Richard Alderman, both published by Thomson/West, and updated yearly. She is also a coauthor of a law school casebook entitled CONSUMER LAW: CASES AND MATERIALS (Thomson/West 3d ed. 2007) and co-editor of a statutory supplement SELECTED CONSUMER STATUTES (Thomson/West 2011). She has written articles and reports on consumer law, and has given presentations at international consumer law meetings in Helsinki, Finland and Auckland, New Zealand. She has also presented at and been the co-chair of the Consumer Issues Conference held yearly at the University of Wyoming since 2001. She has been on the faculty for Teaching Consumer Law, a biennial conference sponsored by the Consumer Law Center at the University of Houston since 2002. Pridgen was elected to the American Law Institute in 2003.

Breakout Session – October 6th at 2:45

21st Century Snake Oil Sales: FTC Regulation of OTC Drug Marketing [presentation]

Like the 19th century medicine shows that travelled the country by covered wagons selling “snake oil” remedies for all types of ailments, the 21st century has vendors traveling the world via the Internet who sell purported cures that have no scientific basis. The Federal Trade Commission is tasked by Congress to police “unfair and deceptive trade practices” which includes the deceptive advertising of over-the-counter drugs. This presentation will provide background on the FTC’s mission, the relationship of the FTC’s activities to FDA drug regulation, and the role of the advertising substantiation doctrine. Professor Pridgen will review current cases, examples of modern day cure-all claims, and will discuss directions in drug marketing enforcement at the FTC.
Kelly Rankin Kelly Rankin attended the University of Wyoming for both his undergraduate and law degrees. Upon graduation, he served briefly in the Lincoln County Attorney’s Office as a deputy county attorney. He then served in the Park County Attorney’s in the same capacity and was elected twice to the position of County Attorney. In 2003, Kelly joined the United States Attorney’s Office where he served in various capacities to include the lead attorney for the District’s Organized Crime Drug Enforcement Task Force and as the presidentially appointed United States Attorney (2008 – 2010). In 2010, Kelly served as counsel to Wyoming Governor Dave Freudenthal. Most recently, Kelly rejoined the U.S. Attorney’s Office and now serves as the Criminal Chief. Kelly also serves as the chairman of the Wyoming Rx Abuse Stakeholders Board.

Panel Discussion -

Prescription Abuse and Misuse in Wyoming

Our panel will discuss the scope of the prescription abuse problem in Wyoming. We will also provide some information on what we are doing to help educate healthcare providers and the public about the problem and tools they can use to prevent it.
Rodney Wambeam Rodney Wambeam, Ph.D. is a Senior Research Scientist at the Wyoming Survey & Analysis Center (WYSAC) of the University of Wyoming (UW). He is also an adjunct professor in the Department of Political Science at UW, where he teaches program evaluation and coordinates a multidisciplinary student certification in this area. Dr. Wambeam completed his Ph.D. at the University of Nebraska in 1999 and served as policy advisor to Nebraska Governor Ben Nelson. He was Director of the Evaluation Research Department at the Nebraska Council to Prevent Alcohol and Drug Abuse before moving home to Wyoming in 2002. At WYSAC, Dr. Wambeam oversees numerous prevention research projects. He was principle investigator of Wyoming’s 21st Century State Incentive Grant and Strategic Prevention Framework State Incentive Grant evaluations. He is currently principle investigator of Wyoming’s Federal Prevention Block Grant evaluation, the Strategic Prevention Framework State Incentive Grant evaluation for the State of Oregon, and numerous other state and local evaluation research projects. In his free time Rodney is an avid runner, is the founder and coach of Wyoming’s only short track ice speed skating team, has been known to organize Muggle Quidditch games for youth and adults, and coaches a Lego robotics team named “The Automaton Lords of Laramie” that recently won the 2010 Wyoming robotics state championship.

Breakout Session – October 6 at 2:45 PM

Substance Abuse Prevention – What Really Works [presentation]

Dr. Wambeam will outline the cutting edge processes that accomplish real outcomes for individuals and for communities in the prevention of substance abuse. This presentation will include a discussion of lessons learned from numerous local and state level efforts to prevent substance abuse, and it will detail the work of real communities in Wyoming that have seen dramatic changes substance use.
Matt Wilson Matthew Wilson is an Associate Professor at the University of Wyoming College of Law. Professor Wilson specializes in intellectual property law, litigation, international business law, international dispute resolution, torts, and Japanese law. From 2003-2009, he served as a law professor for Temple University (Philadelphia) and concurrently served as Senior Associate Dean and General Counsel of Temple University’s 3,000 student campus in Tokyo. Before entering academia, Professor Wilson practiced law at Akerman Senterfitt, a large Florida-based law firm, and served as general counsel for a telecommunications firm. Professor Wilson’s legal practice has included commercial litigation, intellectual property matters, cyberspace law, and general corporate law.

Friday, October 7th 9:45-10:45 a.m. – Breakout Session

Counterfeit Drugs: The Clash Involving Intellectual Property Rights, Health, and Affordable Access to Pharmaceuticals

Counterfeiting is huge business across many industries that reduces corporate profits, threatens reputations, and infringes on various intellectual property rights. In the case of counterfeit drugs, the dangers of counterfeits are even more significant as the health and lives of patients may be at risk. This presentation examines the risks associated with counterfeit drugs and explores the constant struggles between intellectual property rights, health, and the need for access to inexpensive medication.
Stewart Young Professor Young is currently an Assistant Professor of Law and Director of the Prosecution Assistance Program at the University of Wyoming College of Law. Prior to coming to UW, Professor Young served as a federal prosecutor for the Department of Justice in San Diego. During his time as an Assistant United States Attorney, he prosecuted numerous drug trafficking cartels, Mexican Mafia members, and the largest indoor marijuana growing operation on the West Coast. He is a graduate of Stanford Law School and Princeton University.

Thursday, Oct. 6, Panel Discussion, 7:00 PM

Medical Marijuana: Policy Issues (see above)
Tony Young  Tony Young was appointed as the Deputy Chief of Staff for Governor Matthew H. Mead in January of 2011, a role he also occupied for the transition.  Among his many duties, Young will serve as the States Agency Coordinator Prior to severing in the Governor’s Office Young was appointed as the Law Enforcement Coordinator for the United States Attorney’s Office by then United States Attorney David D. Freudenthal in September 1998.  Mr. Young was retained in that position by United States Attorney Matthew H. Mead in October of 2001 and again by United States Attorney Kelly H. Rankin in June of 2008.  Prior to working with the United States Attorney’s Office, Mr. Young was a Special Agent with the Wyoming Attorney General’s Office, Division of Criminal Investigation, assigned as the Supervisor of the Major Investigation Team and the Major Case Unit, which specialized in the investigation and prosecution of major drug trafficking organizations linking drugs to Wyoming.  Additionally, Mr. Young was the state of Wyoming’s first certified forensic computer investigator and has extensive experience in the investigation and prosecution of computer crime, Internet crime, Identity Crime and child exploitation through the use of computers and the Internet.  Mr. Young has been certified as an expert witness on drug trafficking and computer crimes in District Courts throughout Wyoming and Federal Courts in Wyoming, Idaho, Colorado, Utah, Nevada, South Dakota, Arizona, California, Illinois, Ohio, Florida and Washington state.  Additionally, Mr. Young has been called upon to testify to legislative committees and subcommittees for the passage of stricter laws to protect children.  Mr. Young has investigated a wide variety of crimes including homicides, personal and property crimes, major drug investigations, child exploitation cases and public corruption.  He is certified both as a professional peace officer and a professional peace officer instructor.  His education in Criminal Justice was earned at Boise State University. 

Plenary Session & Lunch – October 7th, 12:15 PM

Drugs and Consumers: Perspectives from the Governor's Office [presentation]
Legislative Panel

Charles Scott
John Schiffer
Mike Massie
Elaine Harvey

Oct. 7, Friday, 11:00 to 12:00, Legislative Panel Discussion

Consumer Drug Issues for State Government

The Consumer Issues Conference will feature a panel of Wyoming current and former legislators to discuss state policy issues that have been brought up during the conference. Some topics to be addressed may include: prescription drug abuse, medical marijuana, substance abuse prevention methods, drug enforcement at the border, alternative medicine, regulation of alcohol, drug marketing and health care professionals. Our panelists will be current Wyoming state legislators Charles Scott, John Schiffer, and Elaine Harvey, and former legislator Mike Massie.